Andrew Martin
NHMRC Clinical Trials Centre, NSW, Australia
- This delegate is presenting an abstract at this event.
Dr Andrew Martin is a Senior Lecturer in Biostatistics at the NHMRC Clinical Trials Centre University of Sydney. He has over 20 years’ experience in clinical trials research, gained from senior roles within research-based pharmaceutical organisations and The University of Sydney. His specific interest is in the application of optimal study designs and analysis methods to the development and evaluation of health interventions across all phases of development. This includes the incorporation of quality of life and economic evaluations within clinical trials, and the use of decision analytic techniques to model longer term benefits and costs of interventions. He provides statistical leadership to clinical trial networks in a variety of disease areas to design, undertake, analyse and report on clinical trials. He is also responsible for content development, co-ordination and teaching of post-graduate units in decision analysis and controlled clinical trials at the University of Sydney as well as courses and workshops in clinical trial concept development and statistical methods
Presentations this author is a contributor to:
Discussing and prescribing expensive unfunded anticancer drugs in Australia (#319)
3:00 PM
Deme J Karikios
Posters 2
A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: The P3BEP Trial (ANZUP 1302) (#266)
3:00 PM
Howard Chan
Posters1
Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: ENZARAD (ANZUP 1303) (#273)
3:00 PM
Scott G Williams
Posters1
Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: the ANZUP ENZAMET Trial (ANZUP 1304) (#269)
3:00 PM
Ian Davis
Posters1
Randomised phase 3 double-blind placebo-controlled trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasound-guided prostate biopsy (Pain-Free TRUS B): ANZUP 1501 (#270)
3:00 PM
Ian Davis
Posters1
Randomised phase 3 trial of the addition of Mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer(ANZUP 1301) (#267)
3:00 PM
Howard Chan
Posters1
Analysing the Evidence - the statistics of small numbers (#91)
1:30 PM
Andrew Martin
The evidence base for rare cancers